Cabot Corporation Announces Election of Thierry Vanlancker to Board of Directors
Cabot Corporation Announces Election of Thierry Vanlancker to Board of Directors
BOSTON--(BUSINESS WIRE)--Jul. 12, 2024--Cabot Corporation (NYSE: CBT) announced today that Thierry Vanlancker has been elected to its Board of Directors, effective July 12, 2024. He was also appointed a member of the Audit Committee of the Board of Directors, effective July 12, 2024. Prior to his retirement, Mr. Vanlancker was Chief Executive Officer and a Director of AkzoNobel NV, a multinational paints and coatings company, from 2017 to 2022. Prior to joining AkzoNobel, Mr. Vanlancker was President of Fluoroproducts and the EMEA region at The Chemours Company, a global provider of performance chemicals, from 2015 to 2016, and from 1988 to 2015 held various positions within the chemicals company Dupont. Mr. Vanlancker has been a member of the Board of Directors of SIKA AG, a Swiss multinational specialty chemical company that supplies to the building sector and motor vehicle industry, since 2019 and has been Chairman of the Board since March 2024. He has also been a member of the Board of Directors of Aliaxis SA, a manufacturer of plastic piping systems for buildings, infrastructure, and industry since 2020, and Chairman of the Board since 2022, and a member of the Board of Directors of Stahl, a leading provider of specialty coatings and treatments for flexible substrates, since May 2024, and Etex NV, a manufacturer of building materials, since 2021. Mr. Vanlancker received his MSc Chemical Engineering from the University of Ghent, Belgium.
杜邦公司(NYSE:CBT)今天宣布,Thierry Vanlancker已于2024年7月12日当选为该公司的董事会成员。他还被任命为董事会审计委员会成员,任期自2024年7月12日起。在退休之前,Vanlancker先生曾担任多国涂料和涂层公司AkzoNobel NV的首席执行官和董事,任期为2017年至2022年。在加入AkzoNobel之前,Vanlancker先生曾担任全球性能化学品供应商The Chemours Company的氟化产品和EMEA地区总裁,任职于2015年至2016年。在1988年至2015年期间,他在化学公司杜邦担任各种职务。自2019年起,Vanlancker先生一直担任瑞士跨国特种化学品公司SIKA AG的董事会成员,该公司向建筑业和汽车工业提供供应,并自2024年3月起担任董事长。自2020年以来,他还是建筑管道系统制造商Aliaxis SA的董事会成员,并自2022年起担任董事长,自2024年5月以来,他还是著名的柔性基板特种涂料和处理剂供应商Stahl的董事会成员以及建筑材料制造商Etex NV的董事会成员。Vanlancker先生获得了比利时根特大学的MSc化学工程学位。
Michael M. Morrow, Non-Executive Chair of Cabot's Board of Directors, said, "We are very pleased to welcome Thierry to our Board. Having held various management positions in the chemical sector for more than 30 years, Thierry brings with him extensive global and industrial experience. He possesses in-depth knowledge of strategy, product development, sales, and marketing with specific know-how in chemicals markets and distribution. His strong expertise in the management of international companies, management of differentiated channels to market and in-depth experience with sustainability strategy will further enhance the Board's depth of expertise and capabilities that are necessary to oversee the Company's Creating for Tomorrow strategy."
卡博特的非执行董事主席迈克尔·莫罗(Michael M. Morrow)表示:“我们非常高兴欢迎蒂埃里加入我们的董事会。蒂埃里在化学板块担任多个管理职位超过30年,带来了丰富的全球和工业经验。他拥有深入的策略、产品开发、销售和营销知识,特别是在化学品市场和销售渠道的专业知识。他在国际公司管理、不同渠道市场营销和可持续性策略方面的强大专业知识将进一步增强董事会的专业知识和能力,这是必要的来监督公司的创建未来策略。”
"I am honored to join the Cabot Board of Directors. Cabot has innovative technologies and many exciting opportunities for growth. I look forward to helping Cabot capitalize on those opportunities and further advance their strategy and objectives in the years to come," said Mr. Vanlancker.
“我很荣幸能加入Cabot董事会。Cabot拥有创新技术和许多令人兴奋的增长机会。我期待着帮助Cabot抓住这些机会,并在未来几年进一步推进他们的战略和目标,”Vanlancker先生表示。
About Cabot Corporation
关于Cabot Corporation Cabot Corporation(NYSE:CBT)是一家总部位于马萨诸塞州波士顿的全球性特种化学品和高性能材料公司。该公司是增强碳、特殊碳、电池材料、工程弹性体复合材料、喷墨颜料、母料和导电化合物、烟雾金属氧化物和气凝胶的领先供应商。有关Cabot的更多信息,请访问公司的网站cabotcorp.com。公司鼓励投资者和潜在投资者定期查阅Cabot网站。
Cabot Corporation (NYSE: CBT) is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company is a leading provider of reinforcing carbons, specialty carbons, battery materials, engineered elastomer composites, inkjet colorants, masterbatches and conductive compounds, fumed metal oxides and aerogel. For more information on Cabot, please visit the company's website at cabotcorp.com. The Company encourages investors and potential investors to consult the Cabot website regularly.
前瞻性声明-本发布含有前瞻性声明。所有关于未来预期或预测的声明,包括关于公司战略和增长机会的声明,都是前瞻性声明。这些声明不能保证未来的业绩,并且受到风险、不确定性、潜在不准确的假设和其他一些超出我们控制范围和难以预测的因素的影响,其中一些风险、不确定性、不准确的假设和其他因素可能导致我们实际结果与过去结果以及与前瞻性声明的表达或暗示的结果都不同。影响我们的出业绩的重要因素包括但不限于行业产能利用率和其他特种化学品公司的竞争;针对我们业务的安全、卫生和环境要求和相关限制;与气候变化有关的监管和财务风险;能源和原材料价格和供应的波动,包括针对乌克兰的俄罗斯入侵和美中贸易关系;客户关系的重大不利变化或客户未能履行协议义务;无法实现新产品、应用和技术的发展带来的增长预期;无法实现收购、联盟或合资企业带来的好处,或实现我们的组合管理目标;出人意料的现场开发项目的延迟或成本增加;负向或不确定的全球或地区经济形势和市场机会,包括贸易关系、全球卫生事务或地缘政治冲突;诉讼或法律诉讼;利率、税率、货币汇率控制和外汇汇率波动以及最近发生在阿根廷的货币运动的准确性等方面的准确性我们用来建立呼吸器索赔责任估计的假设。这些因素在我们向证券交易委员会(“SEC”)提交的报告中得到了更充分的讨论,特别是在我们的年度报告中,2013年10月结束的财年10-K中,这些报告在www.sec.gov上提交给了SEC。我们认为,除非情况发生变化,否则无需对任何前瞻性声明进行修订,除非证券和其他适用法律要求我们这样做。
Forward-Looking Statements – This release contains forward-looking statements. All statements that address expectations or projections about the future, including with respect to the Company's strategy and opportunities for growth, are forward-looking statements. These statements are not guarantees of future performance and are subject to risks, uncertainties, potentially inaccurate assumptions, and other factors, some of which are beyond our control and difficult to predict. If known or unknown risks materialize, or should underlying assumptions prove inaccurate, our actual results could differ materially from past results and from those expressed or implied by forward-looking statements. Important factors that could cause our results to differ materially from those expressed or implied in the forward-looking statements include, but are not limited to, industry capacity utilization and competition from other specialty chemical companies; safety, health and environmental requirements and related constraints imposed on our business; regulatory and financial risks related to climate change developments; volatility in the price and availability of energy and raw materials, including with respect to the Russian invasion of Ukraine and the U.S.-China trade relationship; a significant adverse change in a customer relationship or the failure of a customer to perform its obligations under agreements with us; failure to achieve growth expectations from new products, applications and technology developments; failure to realize benefits from acquisitions, alliances, or joint ventures or achieve our portfolio management objectives; unanticipated delays in, or increased cost of site development projects; negative or uncertain worldwide or regional economic conditions and market opportunities, including from trade relations, global health matters or geo-political conflicts; litigation or legal proceedings; interest rates, tax rates, currency exchange controls and fluctuations in foreign currency rates such as the recent currency movements in Argentina; and the accuracy of the assumptions we used in establishing reserves for our share of liability for respirator claims. These factors are discussed more fully in the reports we file with the Securities and Exchange Commission ("SEC"), particularly under the heading "Risk Factors" in our annual report on Form 10-K for our fiscal year ended September 30, 2023, which are filed with the SEC at www.sec.gov. We assume no obligation to provide revisions to any forward-looking statements should circumstances change, except as otherwise required by securities and other applicable laws.
前瞻性声明-本发布含有前瞻性声明。所有关于未来预期或预测的声明,包括关于公司战略和增长机会的声明,都是前瞻性声明。这些声明不能保证未来的业绩,并且受到风险、不确定性、潜在不准确的假设和其他一些超出我们控制范围和难以预测的因素的影响,其中一些风险、不确定性、不准确的假设和其他因素可能导致我们实际结果与过去结果以及与前瞻性声明的表达或暗示的结果都不同。影响我们的出业绩的重要因素包括但不限于行业产能利用率和其他特种化学品公司的竞争;针对我们业务的安全、卫生和环境要求和相关限制;与气候变化有关的监管和财务风险;能源和原材料价格和供应的波动,包括针对乌克兰的俄罗斯入侵和美中贸易关系;客户关系的重大不利变化或客户未能履行协议义务;无法实现新产品、应用和技术的发展带来的增长预期;无法实现收购、联盟或合资企业带来的好处,或实现我们的组合管理目标;出人意料的现场开发项目的延迟或成本增加;负向或不确定的全球或地区经济形势和市场机会,包括贸易关系、全球卫生事务或地缘政治冲突;诉讼或法律诉讼;利率、税率、货币汇率控制和外汇汇率波动以及最近发生在阿根廷的货币运动的准确性等方面的准确性我们用来建立呼吸器索赔责任估计的假设。这些因素在我们向证券交易委员会(“SEC”)提交的报告中得到了更充分的讨论,特别是在我们的年度报告中,2013年10月结束的财年10-K中,这些报告在www.sec.gov上提交给了SEC。我们认为,除非情况发生变化,否则无需对任何前瞻性声明进行修订,除非证券和其他适用法律要求我们这样做。
View source version on businesswire.com:
请查看商业线(businesswire.com)的源版本。
Investor Contact:
Steve Delahunt
(617) 342-6255
投资者联系人:
史蒂夫·德拉亨特
(617) 342-6255
Source: Cabot Corporation
资讯来源:卡博特公司